WHO ICTRP trial
Comparison of Myrtus Communis L. and Descurainia Sophia L. versus salicylic acid…
IRCT2012092710947N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2012092710947N1 |
|---|---|
| Public title | Comparison of Myrtus Communis L. and Descurainia Sophia L. versus salicylic acid in the treatment of wart |
| Scientific title | Comparison the efficacy of Myrtus Communis L. and Descurainia Sophia L. as a method of traditional medicine versus salicylic acid in the treatment of wart |
| Primary sponsor | Vice-Chancellor for Research (Tehran University of Medical Sciences) |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Wart. Viral warts;Viral warts |
| Interventions | Intervention 1: 1) 1 drop of 16.5 % salicylic acid on each wart, once daily for 40 days. The base of salicylic acid is flexible collodion 4%. Primary substances are obtained from Sepidaj Pharmaceutical co. Tehran. Intervention 2: 2) 1 drop… |
| Registration date | Dec 17, 2012 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: